Bayer Cropscience cash flow

·ChemicalsChart ›
Latest FY26
Cash from operations
₹1,079cr 
Capital spending
₹39.9cr 
Free cash flow
₹1,039cr 
Cash from financing
−₹624cr 
₹ crore except per share
Tap a line for its trendFY26Mar 2026FY25Mar 2025FY24Mar 2024FY22 and earlierAlpha Plus
Adjustments to reconcile profit — non-cash items
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
94.0—74.0
19.8—19.6
−32.5—−40.5
Changes in working capital
200—207
−196—12.9
140—−268
Cash from operating activities
855707941
1,242—1,084
164—132
1,079—952
Cash from investing activities
39.9—45.7
8.3—1.7
31.1—30.4
72.5—0.4
Cash from financing activities
——41.8
12.8—7.8
563——
−624—−656
527—296
1,413—1,157
Reference items
874690954
15.4%12.6%18.7%
1,039—906
1.56×—1.29×
164—132
12.8—7.8
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

BAYERCROP₹3,289.80

Bayer Cropscience Ltd.

· Chemicals
₹ CrorePeersUPLPIINDRALLISATULSHKANURASCAMLINFINECLEAN
View
In ₹ Crore except Per Share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation—74.0—94.0
+ Finance Costs—19.6—19.8
+ Interest Income—-40.5—-32.5
Changes in Working Capital
+ Inventories—207.2—199.9
+ Trade Receivables — Current—12.9—-196.2
+ Trade Payables — Current—-268.1—139.5
Cash from Operating Activities
Profit Before Tax (per I/S)—941.4707.4854.9
Cash from Operations (pre-tax)—1,083.7—1,242.0
+ Income Taxes Paid—132.1—163.5
Cash from Operating Activities—951.6—1,078.5
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)—45.7—39.9
+ Sale of Investments (Equity / Debt)—1.7—8.3
+ Interest Received — Investing—30.4—31.1
Cash from Investing Activities—0.4—72.5
Cash from Financing Activities
+ Payment of Lease Liabilities—41.8——
+ Interest Paid—7.8—12.8
+ Dividends Paid———562.8
Cash from Financing Activities—-656.3—-623.8
Net Changes in Cash—295.7—527.2
Closing Cash—1,156.5—1,412.7
Reference Items
EBITDA—954.0689.6873.7
EBITDA Margin %—18.6912.6015.40
Free Cash Flow (CFO − Capex)—905.9—1,038.6
Cash Flow to Net Income—1.29—1.56
Cash Paid for Taxes—132.1—163.5
Cash Paid for Interest—7.8—12.8
As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 85%.